DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lawrence Ginsberg, MD
Red Oak Psychiatry
Principal Investigator - Mohd Azfar Malik, MD
Psych Care Consultants Research
Principal Investigator - Morteza Nadjafi, MD
APG Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Apg Research, Llc
Orlando, Florida, United States
- Kennedy Krieger Institute
Baltimore, Maryland, United States
- Psychcare Consultants
St Louis, Missouri, United States
- Red Oak Psychiatry Associates, Pa
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Oct 2016
- Primary completion
- 1 Nov 2018
- Completion
- 1 Nov 2018
- Last update posted
- 3 Mar 2023
- Registered enrollment
- 17
- Registry id
- NCT02623504
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.